Evaxion AS (EVAX)
3.12
+0.04
(+1.30%)
USD |
NASDAQ |
Sep 04, 16:00
3.11
-0.01
(-0.32%)
After-Hours: 20:00
Evaxion Cash and Short Term Investments (Annual) : 23.23M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 23.23M |
| December 31, 2024 | 5.952M |
| December 31, 2023 | 5.583M |
| December 31, 2022 | 13.18M |
| Date | Value |
|---|---|
| December 31, 2021 | 32.17M |
| December 31, 2020 | 5.834M |
| December 31, 2019 | 9.559M |
| December 31, 2018 | 7.433M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Autolus Therapeutics Plc | 302.21M |
| Cellectis SA | 208.66M |
| DBV Technologies SA | 194.17M |
| Ascendis Pharma A/S | 723.51M |
| Akari Therapeutics Plc | 5.263M |